Besifloxacin supplier | CasNO.141388-76-3

Name
(R)-7-(3-Aminohexahydro-1H-azepin-1-yl)-8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
EINECS 604-773-0
CAS No. 141388-76-3
Article Data1
CAS DataBase
Density 1.47 g/cm³
Solubility
Melting Point
Formula C₁₉H₂₁ClFN₃O₃
Boiling Point 606.976 °C at 760 mmHg
Molecular Weight 393.845
Flash Point 320.887 °C
Transport Information
Appearance
Safety
Risk Codes
Molecular Structure
Hazard Symbols
Synonyms 3-Quinolinecarboxylicacid, 7-(3-aminohexahydro-1H-azepin-1-yl)-8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-,(R)- (9CI);
PSA 88.56000
LogP 3.91000

Besifloxacin Chemical Properties

Empirical Formula of Besifloxacin (CAS NO.141388-76-3): C₁₉H₂₁ClFN₃O₃
Molecular Weight: 393.8397
Nominal Mass: 393 Da
Average Mass: 393.8397 Da
Monoisotopic Mass: 393.125547 Da
Index of Refraction: 1.649
Molar Refractivity: 97.58 cm³
Molar Volume: 267.985 cm³
Surface Tension: 66.937 dyne/cm
Density: 1.47 g/cm³
Flash Point: 320.887 °C
Enthalpy of Vaporization: 94.854 kJ/mol
Boiling Point: 606.976 °C at 760 mmHg
Structure of Besifloxacin (CAS NO.141388-76-3):

Besifloxacin Specification

Besifloxacin , its cas register number is 141388-76-3. It also can be called (R)-7-(3-Aminohexahydro-1H-azepin-1-yl)-8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid ; UNII-BFE2NBZ7NX ; and BOL-303224-A . It is a fourth-generation fluoroquinolone antibiotic, and was developed by SSP Co. Ltd., Japan, and designated SS734. SSP licensed U.S. and European rights to SS734 for ophthalmic use to InSite Vision, Inc., in 2000. Besifloxacin (CAS NO.141388-76-3) has been found to inhibit production of pro-inflammatory cytokines in vitro.

Product Name

(R)-7-(3-Aminohexahydro-1H-azepin-1-yl)-8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid

Besifloxacin Chemical Properties

Besifloxacin Specification

Related Products

Hot Products